Arca
Skip to content
Tools
Tools

Weight gain

Drug research and approvals for weight gain: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 73 studies of weight gain are recruiting on ClinicalTrials.gov, and Health Canada has authorized 6 drug trials for it since 2013.

  • Recruiting worldwide: 73
  • Trials authorized in Canada: 6
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 73 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Phase 3 2

Phase 2 6

Phase 1 or earlier 1

How its trials ended

423 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 90 whose ending is known, 49% met their primary endpoint, 9% missed it and 42% stopped early.

  • Completed, result not reported20849%
  • Ongoing8119%
  • Met its primary endpoint4410%
  • Status unknown4410%
  • Stopped: other or unclear205%
  • Missed its primary endpoint82%
  • Stopped: enrollment or feasibility72%
  • Stopped: sponsor or business decision41%
  • Stopped: lack of efficacy31%
  • Stopped: funding31%
  • Stopped: safety1<1%

Trials authorized in Canada

Newest first; search them all in Canada trials
Mar 28, 2025Safely optimizing body weight with mifomelatide (TCMCB07) in patients with newly diagnosed colorectal cancer (CRC) or pancreatic ductal adenocarcinoma (PDAC)…Mifomelatide (TCMCB07)Endevica BioOngoing
Jul 26, 2022Metformin for antipsychotic-induced weight gain in adults with intellectual disability: a double-blind randomized control trialMetforminCentre for Addiction and Mental HealthOngoing
Jan 26, 2021A pilot open-label study examining glucagon like peptide-1 receptor agonist(GLP-1RA) for antipsychotic induced weight gain: an algorithmic approachOzempic (semaglutide) / Humalog (insulin lispro)Centre for Addiction and Mental HealthClosed
Feb 17, 2016Topiramate in treatment refractory psychotic illness: effects on weight gain and psychopathologyTopiramateCentre for Addiction and Mental HealthClosed
Aug 6, 2013Metformin for attenuation of early clozapine-associated weight gain in a first-episode schizophrenia population: a randomized, placebo-controlled studyMetforminCentre for Addiction and Mental HealthPending
Jul 11, 2013A randomized comparison of osmotic release oral system methylphenidate and cognitive behavioural therapy for the treatment of obese patients with binge eating…MethylphenidateCentre for Addiction and Mental HealthClosed

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.